Blood Filtration and Purification Market
授權報價
| Single User License | $4,500 USD |
| Multiple User License | $5,500 USD |
| Custom Research License | $8,000 USD |
完整報告名稱與涵蓋範圍
Blood Filtration and Purification Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Product (Filtration Kits and Reagents, Membranes, Filters and Consumables, Sample Preparation Systems, Specialty Assays and Columns), By Application (Infectious Disease Diagnostics, Toxicology and Immunodiagnostics, Cancer Diagnostics, Genetic/Molecular Diagnostics, Others), By End User (Clinical Diagnostic Labs, Hospitals, Research and Academic Institutes, Others), By Region & Competition, 2021-2031F
報告摘要
Market Overview
The Global Blood Filtration and Purification Market is forecast to grow from USD 3.89 Billion in 2025 to USD 5.95 Billion by 2031, at a CAGR of 7.34%. These extracorporeal procedures are crucial for removing metabolic waste, toxins, and pathogens when renal or hepatic functions are compromised. This growth is primarily driven by the increasing worldwide incidence of chronic kidney disease (CKD) and the urgent need for sepsis management in intensive care settings, alongside a rising geriatric population susceptible to organ failure. Despite this demand, significant barriers to adoption include the high cost of long-term treatment and a shortage of specialized medical personnel in emerging economies, a challenge highlighted by the estimated 788 million adults globally living with CKD in 2025, underscoring the gap between therapeutic necessity and financial accessibility.
Market Driver
The primary catalyst for market expansion is the escalating global prevalence of Chronic Kidney Disease (CKD) and End-Stage Renal Disease (ESRD), which necessitates continuous renal replacement therapies due to factors like aging populations and increasing metabolic disorders such as diabetes. This demand creates a non-cyclical need for dialysis equipment, exemplified by 831,192 individuals in the United States receiving ESRD treatment by the end of 2023. Further driving the market are technological advancements in portable systems and the growing adoption of home-based dialysis, shifting service delivery towards greater patient autonomy, with over 15% of patients at a major provider utilizing home-based modalities in 2024, supported by industry restructuring like Baxter's USD 3.8 billion divestiture of its Kidney Care business.
Market Challenge
A formidable barrier to the Global Blood Filtration and Purification Market's growth is the prohibitive cost of long-term treatment combined with a scarcity of specialized medical personnel, particularly in emerging economies. This economic constraint limits adoption despite substantial clinical need, as high capital requirements for equipment and recurring consumable expenses often exceed healthcare budgets in developing nations, hindering market penetration. Additionally, the effective deployment of sophisticated purification technologies is bottlenecked by a critical shortage of trained practitioners, including nephrologists and specialized nurses, required for managing extracorporeal procedures. This human capital deficit hampers service scalability, as reflected by an approximately 73% adult nephrology fellowship fill rate in 2025, stifling the market's capacity to deliver care effectively.
Market Trends
The sector is being transformed by the integration of Artificial Intelligence (AI) and the Internet of Things (IoT), moving focus from reactive treatment to predictive patient management. This involves embedding algorithms into dialysis infrastructure for real-time biometric monitoring and forecasting complications to reduce hospital readmissions, as demonstrated by a company introducing an AI-driven model to predict fall risks in dialysis patients. Concurrently, the market is seeing a significant expansion in the use of specialized hemoperfusion and adsorption cartridges for sepsis management. These therapies are designed to remove inflammatory mediators and cytokines from critically ill patients, addressing a gap in conventional intensive care protocols, with one leading technology already deployed in nearly 300,000 human treatments globally.
Key Market Players
* Fresenius Medical Care AG & Co. KGaA
* Baxter International Inc.
* B. Braun Melsungen AG
* Nikkiso Co., Ltd.
* Terumo Corporation
* Asahi Kasei Medical Co., Ltd.
* Kawasumi Laboratories, Inc.
* Medtronic plc
* Toray Medical Co., Ltd.
* Jafron Biomedical Co., Ltd.
Report Scope
In this report, the Global Blood Filtration and Purification Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:
# Blood Filtration and Purification Market, By Product
* Filtration Kits and Reagents
* Membranes
* Filters and Consumables
* Sample Preparation Systems
* Specialty Assays
* Columns
# Blood Filtration and Purification Market, By Application
* Infectious Disease Diagnostics
* Toxicology and Immunodiagnostics
* Cancer Diagnostics
* Genetic/Molecular Diagnostics
* Others
# Blood Filtration and Purification Market, By End User
* Clinical Diagnostic Labs
* Hospitals
* Research and Academic Institutes
* Others
# Blood Filtration and Purification Market, By Region
* North America
United States
Canada
Mexico
* Europe
France
United Kingdom
Italy
Germany
Spain
* Asia Pacific
China
India
Japan
Australia
South Korea
* South America
Brazil
Argentina
Colombia
* Middle East & Africa
South Africa
Saudi Arabia
UAE
Competitive Landscape
Company Profiles: Detailed analysis of the major companies present in the Global Blood Filtration and Purification Market.
Available Customizations:
Global Blood Filtration and Purification Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:
Company Information
* Detailed analysis and profiling of additional market players (up to five).
目錄 Table of Contents
1. Product Overview
1.1. Market Definition
1.2. Scope of the Market
1.2.1. Markets Covered
1.2.2. Years Considered for Study
1.2.3. Key Market Segmentations
2. Research Methodology
2.1. Objective of the Study
2.2. Baseline Methodology
2.3. Key Industry Partners
2.4. Major Association and Secondary Sources
2.5. Forecasting Methodology
2.6. Data Triangulation & Validation
2.7. Assumptions and Limitations
3. Executive Summary
3.1. Overview of the Market
3.2. Overview of Key Market Segmentations
3.3. Overview of Key Market Players
3.4. Overview of Key Regions/Countries
3.5. Overview of Market Drivers, Challenges, Trends
4. Voice of Customer
5. Global Blood Filtration and Purification Market Outlook
5.1. Market Size & Forecast
5.1.1. By Value
5.2. Market Share & Forecast
5.2.1. By Product (Filtration Kits and Reagents, Membranes, Filters and Consumables, Sample Preparation Systems, Specialty Assays, Columns)
5.2.2. By Application (Infectious Disease Diagnostics, Toxicology and Immunodiagnostics, Cancer Diagnostics, Genetic/Molecular Diagnostics, Others)
5.2.3. By End User (Clinical Diagnostic Labs, Hospitals, Research and Academic Institutes, Others)
5.2.4. By Region
5.2.5. By Company (2025)
5.3. Market Map
6. North America Blood Filtration and Purification Market Outlook
6.1. Market Size & Forecast
6.1.1. By Value
6.2. Market Share & Forecast
6.2.1. By Product
6.2.2. By Application
6.2.3. By End User
6.2.4. By Country
6.3. North America: Country Analysis
6.3.1. United States Blood Filtration and Purification Market Outlook
6.3.1.1. Market Size & Forecast
6.3.1.1.1. By Value
6.3.1.2. Market Share & Forecast
6.3.1.2.1. By Product
6.3.1.2.2. By Application
6.3.1.2.3. By End User
6.3.2. Canada Blood Filtration and Purification Market Outlook
6.3.2.1. Market Size & Forecast
6.3.2.1.1. By Value
6.3.2.2. Market Share & Forecast
6.3.2.2.1. By Product
6.3.2.2.2. By Application
6.3.2.2.3. By End User
6.3.3. Mexico Blood Filtration and Purification Market Outlook
6.3.3.1. Market Size & Forecast
6.3.3.1.1. By Value
6.3.3.2. Market Share & Forecast
6.3.3.2.1. By Product
6.3.3.2.2. By Application
6.3.3.2.3. By End User
7. Europe Blood Filtration and Purification Market Outlook
7.1. Market Size & Forecast
7.1.1. By Value
7.2. Market Share & Forecast
7.2.1. By Product
7.2.2. By Application
7.2.3. By End User
7.2.4. By Country
7.3. Europe: Country Analysis
7.3.1. Germany Blood Filtration and Purification Market Outlook
7.3.1.1. Market Size & Forecast
7.3.1.1.1. By Value
7.3.1.2. Market Share & Forecast
7.3.1.2.1. By Product
7.3.1.2.2. By Application
7.3.1.2.3. By End User
7.3.2. France Blood Filtration and Purification Market Outlook
7.3.2.1. Market Size & Forecast
7.3.2.1.1. By Value
7.3.2.2. Market Share & Forecast
7.3.2.2.1. By Product
7.3.2.2.2. By Application
7.3.2.2.3. By End User
7.3.3. United Kingdom Blood Filtration and Purification Market Outlook
7.3.3.1. Market Size & Forecast
7.3.3.1.1. By Value
7.3.3.2. Market Share & Forecast
7.3.3.2.1. By Product
7.3.3.2.2. By Application
7.3.3.2.3. By End User
7.3.4. Italy Blood Filtration and Purification Market Outlook
7.3.4.1. Market Size & Forecast
7.3.4.1.1. By Value
7.3.4.2. Market Share & Forecast
7.3.4.2.1. By Product
7.3.4.2.2. By Application
7.3.4.2.3. By End User
7.3.5. Spain Blood Filtration and Purification Market Outlook
7.3.5.1. Market Size & Forecast
7.3.5.1.1. By Value
7.3.5.2. Market Share & Forecast
7.3.5.2.1. By Product
7.3.5.2.2. By Application
7.3.5.2.3. By End User
8. Asia Pacific Blood Filtration and Purification Market Outlook
8.1. Market Size & Forecast
8.1.1. By Value
8.2. Market Share & Forecast
8.2.1. By Product
8.2.2. By Application
8.2.3. By End User
8.2.4. By Country
8.3. Asia Pacific: Country Analysis
8.3.1. China Blood Filtration and Purification Market Outlook
8.3.1.1. Market Size & Forecast
8.3.1.1.1. By Value
8.3.1.2. Market Share & Forecast
8.3.1.2.1. By Product
8.3.1.2.2. By Application
8.3.1.2.3. By End User
8.3.2. India Blood Filtration and Purification Market Outlook
8.3.2.1. Market Size & Forecast
8.3.2.1.1. By Value
8.3.2.2. Market Share & Forecast
8.3.2.2.1. By Product
8.3.2.2.2. By Application
8.3.2.2.3. By End User
8.3.3. Japan Blood Filtration and Purification Market Outlook
8.3.3.1. Market Size & Forecast
8.3.3.1.1. By Value
8.3.3.2. Market Share & Forecast
8.3.3.2.1. By Product
8.3.3.2.2. By Application
8.3.3.2.3. By End User
8.3.4. South Korea Blood Filtration and Purification Market Outlook
8.3.4.1. Market Size & Forecast
8.3.4.1.1. By Value
8.3.4.2. Market Share & Forecast
8.3.4.2.1. By Product
8.3.4.2.2. By Application
8.3.4.2.3. By End User
8.3.5. Australia Blood Filtration and Purification Market Outlook
8.3.5.1. Market Size & Forecast
8.3.5.1.1. By Value
8.3.5.2. Market Share & Forecast
8.3.5.2.1. By Product
8.3.5.2.2. By Application
8.3.5.2.3. By End User
9. Middle East & Africa Blood Filtration and Purification Market Outlook
9.1. Market Size & Forecast
9.1.1. By Value
9.2. Market Share & Forecast
9.2.1. By Product
9.2.2. By Application
9.2.3. By End User
9.2.4. By Country
9.3. Middle East & Africa: Country Analysis
9.3.1. Saudi Arabia Blood Filtration and Purification Market Outlook
9.3.1.1. Market Size & Forecast
9.3.1.1.1. By Value
9.3.1.2. Market Share & Forecast
9.3.1.2.1. By Product
9.3.1.2.2. By Application
9.3.1.2.3. By End User
9.3.2. UAE Blood Filtration and Purification Market Outlook
9.3.2.1. Market Size & Forecast
9.3.2.1.1. By Value
9.3.2.2. Market Share & Forecast
9.3.2.2.1. By Product
9.3.2.2.2. By Application
9.3.2.2.3. By End User
9.3.3. South Africa Blood Filtration and Purification Market Outlook
9.3.3.1. Market Size & Forecast
9.3.3.1.1. By Value
9.3.3.2. Market Share & Forecast
9.3.3.2.1. By Product
9.3.3.2.2. By Application
9.3.3.2.3. By End User
10. South America Blood Filtration and Purification Market Outlook
10.1. Market Size & Forecast
10.1.1. By Value
10.2. Market Share & Forecast
10.2.1. By Product
10.2.2. By Application
10.2.3. By End User
10.2.4. By Country
10.3. South America: Country Analysis
10.3.1. Brazil Blood Filtration and Purification Market Outlook
10.3.1.1. Market Size & Forecast
10.3.1.1.1. By Value
10.3.1.2. Market Share & Forecast
10.3.1.2.1. By Product
10.3.1.2.2. By Application
10.3.1.2.3. By End User
10.3.2. Colombia Blood Filtration and Purification Market Outlook
10.3.2.1. Market Size & Forecast
10.3.2.1.1. By Value
10.3.2.2. Market Share & Forecast
10.3.2.2.1. By Product
10.3.2.2.2. By Application
10.3.2.2.3. By End User
10.3.3. Argentina Blood Filtration and Purification Market Outlook
10.3.3.1. Market Size & Forecast
10.3.3.1.1. By Value
10.3.3.2. Market Share & Forecast
10.3.3.2.1. By Product
10.3.3.2.2. By Application
10.3.3.2.3. By End User
11. Market Dynamics
11.1. Drivers
11.2. Challenges
12. Market Trends & Developments
12.1. Merger & Acquisition (If Any)
12.2. Product Launches (If Any)
12.3. Recent Developments
13. Global Blood Filtration and Purification Market: SWOT Analysis
14. Porter's Five Forces Analysis
14.1. Competition in the Industry
14.2. Potential of New Entrants
14.3. Power of Suppliers
14.4. Power of Customers
14.5. Threat of Substitute Products
15. Competitive Landscape
15.1. Fresenius Medical Care AG & Co. KGaA
15.1.1. Business Overview
15.1.2. Products & Services
15.1.3. Recent Developments
15.1.4. Key Personnel
15.1.5. SWOT Analysis
15.2. Baxter International Inc.
15.3. B. Braun Melsungen AG
15.4. Nikkiso Co., Ltd.
15.5. Terumo Corporation
15.6. Asahi Kasei Medical Co., Ltd.
15.7. Kawasumi Laboratories, Inc.
15.8. Medtronic plc
15.9. Toray Medical Co., Ltd.
15.10. Jafron Biomedical Co., Ltd.
16. Strategic Recommendations
17. About Us & Disclaimer
提及公司
同分類最新報告（醫療與生命科學）
常見問題
這份報告可以先索取樣本嗎？
可以。建議購買前先申請樣本，提出申請後約 2 個工作天內提供，您可以先確認內容涵蓋範圍是否符合需求。
報告價格如何計算？
報告以美元標價，台幣報價依當日匯率換算並加計 5% 營業稅。不同授權版本（單人／多人／企業全站）價格不同，量子訊息會評估您的使用情境後提供最優惠報價。
下單後多久交付？如何付款？
一般 3–7 個工作天交付，實際依出版商狀況於下單前確認。收到報告確認無誤後開立台幣發票，30 天內電匯付款即可。
量子訊息有限公司為 TechSci Research 在台灣的授權代理，提供報告購買、樣本申請與授權諮詢。電話 +886 2 7751 5192 ・ 聯絡我們